Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Green Jeremy
Relationship:   Former 10% Owner and D...
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   31    
Direct Shares   49,793    

Indirect Shares

   116,486,068      
Direct Value   $251,953    

Indirect Value

   $345,683,051      
Total Shares   116,535,861      
Total Value   $345,935,004      


Syros Pharmaceuticals, Inc. $251,953 Syros Pharmaceuticals, Inc. $251,953
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    9   
    1    

     Stock price went up :
    2   
    0    
     Stock price went down :
    7   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.9%
 -38.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amicus Therapeutics Inc FOLD 10% Owner 2016-06-03 0 2016-06-03 12,956,446    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2016-07-06 49,793 2016-07-06 0    Premium*  
            Xeris Pharmaceuticals Inc XERS 10% Owner 2018-06-25 0 2019-02-19 3,000,642    Premium*  
            Allakos Inc. ALLK 10% Owner 2018-07-23 0 2018-07-23 1,009,090    Premium*  
            Replimune Group Inc REPL 10% Owner 2018-07-24 0 2018-07-24 779,655    Premium*  
            Fate Therapeutics Inc FATE Director, 10% Owner 2018-09-25 0 2023-12-26 13,180,388    Premium*  
            Gritstone Oncology, Inc. GRTS 10% Owner 2018-10-02 0 2018-10-02 1,394,529    Premium*  
            Vapotherm Inc VAPO 10% Owner 2018-11-16 0 2018-11-16 959,540    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2019-02-19 0 2019-02-19 807,256    Premium*  
            Alder Biopharmaceuticals Inc ALDR Director 2019-03-04 0 2019-10-22 0    Premium*  
            Akero Therapeutics, Inc. AKRO 10% Owner 2019-06-24 0 2019-06-24 743,802    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 715,306    Premium*  
            Stoke Therapeutics, Inc. STOK 10% Owner 2019-06-21 0 2019-06-21 671,808    Premium*  
            Igm Biosciences, Inc. IGMS 10% Owner 2019-09-20 0 2024-03-29 3,078,332    Premium*  
            Aprea Therapeutics, Inc. APRE 10% Owner 2019-10-07 0 2020-12-28 1,768,718    Premium*  
            Cabaletta Bio, Inc. CABA 10% Owner 2019-10-29 0 2019-10-29 696,378    Premium*  
            Beam Therapeutics Inc. BEAM 10% Owner 2020-02-10 0 2020-02-10 1,161,458    Premium*  
            Neurogene NGNE 10% Owner 2020-03-27 0 2020-04-02 4,041,211    Premium*  
            Pliant Therapeutics, Inc. PLRX 10% Owner 2020-06-05 0 2020-06-05 1,910,657    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2020-06-23 1,586,174    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2020-07-28 0 2020-07-28 1,176,470    Premium*  
            Annexon, Inc. ANNX 10% Owner 2020-07-28 0 2020-07-28 1,596,222    Premium*  
            Allovir Inc ALVR 10% Owner 2020-08-03 0 2020-08-03 823,371    Premium*  
            Kymera Therapeutics, Inc. KYMR 10% Owner 2020-08-25 0 2020-08-25 1,630,660    Premium*  
            Augmedix, Inc AUGX Director, 10% Owner 2020-10-05 0 2024-03-15 16,408,909    Premium*  
            Shattuck Labs, Inc. STTK Director, 10% Owner 2020-10-14 0 2024-03-28 5,615,489    Premium*  
            MedAvail Holdings, Inc MDVL Director, 10% Owner 0 2022-04-04 25,192,751    Premium*  
            Verve Therapeutics, Inc. VERV 10% Owner 2021-06-21 0 2021-06-21 1,936,530    Premium*  
            Absci Corp ABSI Director 2021-07-26 0 2024-03-01 8,253,316    Premium*  
            Adagio Therapeutics, Inc. ADGI 10% Owner 2021-08-10 0 2021-08-10 3,390,960    Premium*  
            Science 37 Holdings, Inc SNCE Former 10% Owner and D... 2021-10-06 0 2024-03-12 0    Premium*  
* Premium Members only  

Records found :    110         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2016-06-03 3 IO $0.00 $0 I/I 0 12,890,146 -
NGNE Neurogene 10% Owner   –       –       •   2020-03-26 3 IO $0.00 $0 I/I 0 3,866,579 -
AUGX Augmedix, Inc Director   –       •       •   2020-10-05 3 IO $0.00 $0 I/I 0 7,755,327 -
MDVL MedAvail Holdings, Inc Director   –       •       •   2020-11-17 3 IO $0.00 $0 I/I 0 11,724,726 %
SNCE Science 37 Holdings, Inc Director   –       •       •   2021-10-06 3 IO $0.00 $0 I/I 0 5,000,000 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2021-03-31 4 A $0.00 $0 I/I 130 3,426,297 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2021-06-30 4 A $0.00 $0 I/I 130 3,426,427 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2021-09-30 4 A $0.00 $0 I/I 130 3,426,557 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2021-12-31 4 A $0.00 $0 I/I 130 3,335,587 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2020-04-01 4 A $0.00 $0 I/I 178 3,144,178 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2020-07-01 4 A $0.00 $0 I/I 178 3,144,356 0 -
IGMS Igm Biosciences, Inc. Director   –       •       •   2020-10-01 4 A $0.00 $0 I/I 178 3,425,989 0 -
IGMS Igm Biosciences, Inc. Director   –       •       •   2020-12-31 4 A $0.00 $0 I/I 178 3,426,167 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2022-03-31 4 A $0.00 $0 I/I 230 3,335,817 0 -
IGMS Igm Biosciences, Inc. Director   –       •       •   2022-06-30 4 A $0.00 $0 I/I 230 3,336,047 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2022-09-30 4 A $0.00 $0 I/I 230 3,336,277 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2022-12-30 4 A $0.00 $0 I/I 230 3,336,507 0 -
IGMS Igm Biosciences, Inc. Director   –       •      –    2023-06-30 4 A $0.00 $0 I/I 492 2,974,678 0 -
IGMS Igm Biosciences, Inc. Director   –       •      –    2023-09-29 4 A $0.00 $0 I/I 492 2,975,170 0 -
IGMS Igm Biosciences, Inc. Director   –       •      –    2023-12-29 4 A $0.00 $0 I/I 492 2,975,662 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2024-03-29 4 A $0.00 $0 I/I 1,734 3,078,332 0 -
AUGX Augmedix, Inc Director   –       •       •   2023-12-15 4 A $0.00 $0 I/I 1,767 16,405,784 0 -
AUGX Augmedix, Inc Director   –       •       •   2023-08-31 4 A $4.78 $10,000 I/I 2,092 15,654,017 0 -
FATE Fate Therapeutics Inc Director   –       •       •   2021-06-02 4 A $0.00 $0 I/I 2,681 12,959,903 0 -
AUGX Augmedix, Inc Director   –       •       •   2024-03-15 4 A $0.00 $0 I/I 3,125 16,408,909 0 -
  110  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us